UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Completed
Unique ID issued by UMIN UMIN000040079
Receipt No. R000045633
Scientific Title Effects of intensive exercise on cognitive dysfunction in patients with pure cerebellar degeneration: a single-arm pilot study
Date of disclosure of the study information 2020/04/30
Last modified on 2021/10/20

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Effects of rehabilitation on cognitive dysfunction in spinocerebellar degeneration
Acronym Examination of rehabilitation effect of spinocerebellar degeneration
Scientific Title Effects of intensive exercise on cognitive dysfunction in patients with pure cerebellar degeneration: a single-arm pilot study
Scientific Title:Acronym Effect of exercise on cognitive dysfunction in SCD
Region
Japan

Condition
Condition spinocerebellar degeneration
Classification by specialty
Neurology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To clarify whether rehabilitation is effective for cognitive dysfunction in spinocerebellar degeneration
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Cognitive function evaluation
Evaluate before intervention and after 4 weeks
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Maneuver
Interventions/Control_1 4 weeks of rehabilitation
6 times a week
3 hours a day rehabilitation
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
50 years-old <=
Age-upper limit
79 years-old >=
Gender Male and Female
Key inclusion criteria Patients with spinocerebellar degeneration
Key exclusion criteria Exclusion criteria included history of stroke, depression, complications including severe infection, deep vein thrombosis, orthopedic diseases causing pain during gait, unstable angina and cardiopulmonary disease causing dyspnea during exercise, and recent history of surgical intervention, including coronary artery bypass graft.
Target sample size 16

Research contact person
Name of lead principal investigator
1st name Toshiya
Middle name
Last name Shimamoto
Organization kumamoto southern regional hospital
Division name department of rehabilitation
Zip code 861-4214
Address mu-banchi mainohara jhonan-machi minami-ku kumamoto
TEL 0964-28-2555
Email sentyoukansetu@icloud.com

Public contact
Name of contact person
1st name Toshiya
Middle name
Last name Shimamoto
Organization kumamoto southern regional hospital
Division name department of rehabilitation
Zip code 861-4214
Address mu-banchi mainohara jhonan-machi minami-ku kumamoto
TEL 0964-28-2555
Homepage URL
Email sentyoukansetu@icloud.com

Sponsor
Institute kumamoto southern regional hospital
Institute
Department

Funding Source
Organization none
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization N/A
Address N/A
Tel N/A
Email N/A

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2020 Year 04 Month 30 Day

Related information
URL releasing protocol https://upload.umin.ac.jp/cgi-bin/ctr_e/ctr_view.cgi?recptno=R000045633
Publication of results Published

Result
URL related to results and publications https://upload.umin.ac.jp/cgi-bin/ctr_e/ctr_view.cgi?recptno=R000045633
Number of participants that the trial has enrolled 16
Results Motor function and ADL
SARA scores significantly improved from 10.7 to 8.1 points after exercise. BBS scores significantly increased from 43.6 to 48.8 points after exercise. FIM scores significantly increased from 119.7 to 122.3 points after exercise.
Cognitive function
MMSE scores significantly improved from 27.7 to 29.0 points after exercise. FAB scores significantly increased from 14.8 to 15.8 points after exercise. MoCA-J scores significantly increased from 24.6 to 26.7 points after exercise.
Results date posted
2021 Year 10 Month 20 Day
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics We enrolled patients diagnosed with SCD of the purely cerebellar type, identified by an expert neurologist based on the results of DNA analysis. Patients had to be capable of independent activities of daily living and walking in order to be eligible for the study. Exclusion criteria included any abnormalities other than those within the cerebellum on magnetic resonance imaging and voxel based specific regional analysis system for Alzheimer disease, muscle weakness, marked range of motion limitation, sensory deficits including superficial deep sensation, vestibular dysfunction, motor dysfunction due to other diseases, and mental illness.
Participant flow This study was a comparative study with a control group for the assessment of cognitive function, but a single-arm pilot study with only an intervention group and no comparison group for the assessment after the exercise intervention. Each participant in the control group underwent cognitive function tests. Participants in the patient group underwent cognitive and motor function and ADL assessments on admission. The same assessments were then performed again after intensive exercise therapy to evaluate the effect of exercise.
Adverse events No adverse events were observed.
Outcome measures Evaluation of motor function and ADL
1) Scale for the Assessment and Rating of Ataxia (SARA)
2) Berg Balance Scale (BBS)
3) Functional Independence Measure (FIM).
Evaluation of cognitive function
1) Mini-Mental State Examination (MMSE)
2) Frontal Assessment Battery (FAB)
3) Montreal Cognitive Assessment-Japanese (MoCA-J).
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2018 Year 04 Month 01 Day
Date of IRB
2018 Year 01 Month 10 Day
Anticipated trial start date
2016 Year 01 Month 01 Day
Last follow-up date
2020 Year 01 Month 01 Day
Date of closure to data entry
2020 Year 01 Month 30 Day
Date trial data considered complete
2020 Year 01 Month 30 Day
Date analysis concluded
2021 Year 04 Month 01 Day

Other
Other related information

Management information
Registered date
2020 Year 04 Month 06 Day
Last modified on
2021 Year 10 Month 20 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045633

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name
2021/04/22 UMIN英語登録用.xlsx


Contact us.